With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.1351279-73-6,4,4′,4”,4”’-(Ethene-1,1,2,2-tetrayl)tetrabenzoic acid,as a common compound, the synthetic route is as follows.
Weigh H4TCPE (30mg, 0.06mmol), Ni(NO3)2?6H2O (166mg, 0.57mmol) and L-Pro (12mg, 0.1mmol) was dissolved in 2mL water and 4mL N, N- dimethylformamide mixed solution, stirred for 12 hours until homogeneity, placed in an oven, heated at 100 deg. C for 72 hours, the oven was turned off, cooled to room temperature, a green bulk crystal was produced, filtered and dried, yield 10%.
1351279-73-6, 1351279-73-6 4,4′,4”,4”’-(Ethene-1,1,2,2-tetrayl)tetrabenzoic acid 101553689, acatalyst-ligand compound, is more and more widely used in various fields.
Reference£º
Patent; Dalian University of Technology; Duan, Chunying; Zhou, Zhen; Lu, Yang; He, Cheng; (12 pag.)CN105348071; (2016); A;,
Metal catalyst and ligand design
Ligand Template Strategies for Catalyst Encapsulation – NCBI